EFFECT OF A CONJUGATED BILE-SALT ON THE PULMONARY ABSORPTION OF INSULIN IN RATS

被引:0
|
作者
LI, YP [1 ]
SHAO, Z [1 ]
DENICOLA, DB [1 ]
MITRA, AK [1 ]
机构
[1] PURDUE UNIV,SCH PHARM & PHARMACAL SCI,DEPT IND & PHYS PHARM,W LAFAYETTE,IN 47907
关键词
INSULIN; PULMONARY DELIVERY; SODIUM GLYCOCHOLATE (NAGC); INTRATRACHEAL INSTILLATION; TWEEN-80;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pulmonary delivery of insulin with sodium glycocholate (NaGC) as the absorption promoter has been investigated using intratracheal instillation method. The absolute bioavailability of insulin solution at a dose level of 1 U kg-1 was found to be 78.8% and 9.1% respectively in the presence and absence of 20 mM NaGC, representing a 9-fold increase. Significantly enhanced hypoglycemic effects were also observed following intratracheal administration of 1 U kg-1 insulin with NaGC. The pharmacological availability values were found to be 11.08, 18.97, 21.16, 23.37, and 23.44% in the presence of 0, 5, 10, 20 and 30 mM of NaGC, respectively. On the other hand, Tween 80, at a concentration of 20 mM, resulted in a pharmacological availability of only 16.04% while both surfactants exhibited considerable reductions in the air-water interfacial tension. Histological studies failed to reveal any observable alteration in the epithelial integrity even at 30 mM NaGC concentration. The mechanisms of bile salt-mediated pulmonary insulin absorption have therefore been postulated to be a combination of a number of factors including dissociation of insulin oligamers, dilation of pulmonary epithelial tight junctions, surface tension reduction, aminopeptidase inhibition, and ciliostatic effect.
引用
收藏
页码:216 / 221
页数:6
相关论文
共 50 条
  • [1] CHRONIC EFFECT OF ORAL CHOLESTYRAMINE, A BILE-SALT SEQUESTRANT, AND EXOGENOUS CHOLECYSTOKININ ON INSULIN RELEASE IN RATS
    KOGIRE, M
    GOMEZ, G
    UCHIDA, T
    ISHIZUKA, J
    GREELEY, GH
    THOMPSON, JC
    PANCREAS, 1992, 7 (01) : 15 - 20
  • [2] DISSOCIATION OF INSULIN OLIGOMERS BY BILE-SALT MICELLES AND ITS EFFECT ON ALPHA-CHYMOTRYPSIN-MEDIATED PROTEOLYTIC DEGRADATION
    LI, YP
    SHAO, ZZ
    MITRA, AK
    PHARMACEUTICAL RESEARCH, 1992, 9 (07) : 864 - 869
  • [3] BILE-SALT FATTY-ACID MIXED MICELLES AS NASAL ABSORPTION PROMOTERS OF PEPTIDES .2. INVIVO NASAL ABSORPTION OF INSULIN IN RATS AND EFFECTS OF MIXED MICELLES ON THE MORPHOLOGICAL INTEGRITY OF THE NASAL-MUCOSA
    TENGAMNUAY, P
    MITRA, AK
    PHARMACEUTICAL RESEARCH, 1990, 7 (04) : 370 - 375
  • [4] Enhancing Effect of Bile Salts on Gastrointestinal Absorption of Insulin
    Jalali, Amir
    Moghimipour, Eskandar
    Akhgari, Abbas
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 13 (11) : 1797 - 1802
  • [5] Facilitation of Pulmonary Insulin Absorption by H-MAP: Pharmacokinetics and Pharmacodynamics in Rats
    Sandra Suarez
    Lucila Garcia-Contreras
    Donald Sarubbi
    Elizabeth Flanders
    Doris O'Toole
    John Smart
    Anthony J. Hickey
    Pharmaceutical Research, 2001, 18 : 1677 - 1684
  • [6] Facilitation of pulmonary insulin absorption by H-MAP: Pharmacokinetics and pharmacodynamics in rats
    Suarez, S
    Garcia-Contreras, L
    Sarubbi, D
    Flanders, E
    O'Toole, D
    Smart, J
    Hickey, AJ
    PHARMACEUTICAL RESEARCH, 2001, 18 (12) : 1677 - 1684
  • [7] Absorption enhancing effect of Labrasol on the intestinal absorption of insulin in rats
    Eaimtrakarn, S
    Prasad, YVR
    Ohno, T
    Konishi, T
    Yoshikawa, Y
    Shibata, N
    Takada, K
    JOURNAL OF DRUG TARGETING, 2002, 10 (03) : 255 - 260
  • [8] EFFECT OF POLYMERS AND MICROSPHERES ON THE NASAL ABSORPTION OF INSULIN IN RATS
    RYDEN, L
    EDMAN, P
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 83 (1-3) : 1 - 10
  • [9] Investigation of the effect of anaesthesia on nasal absorption of insulin in rats
    Mayor, SH
    Illum, L
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 149 (01) : 123 - 129
  • [10] Effect of aminated gelatin on the nasal absorption of insulin in rats
    Seki, T
    Kanbayashi, H
    Nagao, T
    Chono, S
    Tomita, M
    Hayashi, M
    Tabata, Y
    Morimoto, K
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (03) : 510 - 514